PharmaCielo(TSE:PCLO)
CA$0.04-0.01 (-22.22%)
TSE:PCLO
PharmaCielo financials statements
CA$0.04
At close:-0.01 (-22.22%)
Want to see TSE:PCLO full AI Analyst Report?
PharmaCielo (PCLO) Income Statement
53 Followers
PharmaCielo Income Statement
Last quarter (Q2 2026), PharmaCielo's total revenue was C$1.39M, an increase of 75.22% from the same quarter last year. In Q2, PharmaCielo's net income was C$-1.44M. See PharmaCielo’s key income statements, including revenue, expenses, profit, and income.
| Income Statement | Dec 25 | Dec 24 | Jun 24 | Mar 23 | Mar 22 |
|---|---|---|---|---|---|
| C$ 2.61M | C$ 3.48M | C$ 1.54M | C$ 5.31M | C$ 1.94M | |
| C$ 756.40K | C$ 730.88K | C$ -1.37M | C$ 827.06K | C$ -4.31M | |
| C$ 4.58M | C$ 730.88K | C$ 8.33M | C$ 12.26M | C$ 20.89M | |
| Depreciation and Amortization | C$ 997.68K | C$ 1.27M | C$ 1.41M | C$ 1.58M | C$ 1.26M |
| C$ -1.00M | C$ -4.60M | C$ -12.19M | C$ -10.50M | C$ -24.34M | |
| C$ -3.82M | C$ -4.90M | C$ -9.70M | C$ -11.46M | C$ -25.46M | |
| C$ -729.91K | C$ -9.14M | C$ -6.60M | C$ -3.89M | C$ -2.89M | |
| C$ -4.55M | C$ -9.14M | C$ -16.30M | C$ -14.52M | C$ -26.63M | |
| C$ -4.55M | C$ -9.14M | C$ -16.30M | C$ -16.04M | C$ -26.92M | |
| Per Share Metrics | |||||
| Basic EPS | C$ -0.03 | C$ -0.01 | C$ -0.10 | C$ -0.11 | C$ -0.18 |
| Diluted EPS | C$ -0.03 | C$ -0.01 | C$ -0.10 | C$ -0.11 | C$ -0.18 |
| Weighted Average Shares Outstanding | 187.98M | 175.25M | 160.08M | 150.98M | 145.64M |
| Weighted Average Shares Outstanding (Diluted) | 187.98M | 175.25M | 160.08M | 150.98M | 145.64M |
Currency in CAD

